Meiji (OTCMKTS:MEJHY) is a Japanese-based holding company known for its diverse portfolio in the food and pharmaceutical sectors. Headquartered in Tokyo, Meiji leverages a network of subsidiaries to develop, manufacture and market products that cater to consumers’ nutritional and health needs. Through its ADR program, the company offers international investors exposure to its operations, which span research-driven pharmaceuticals and globally recognized food and beverage brands.
In its food business, Meiji produces a wide array of dairy products, including milk, yogurt, cheese and ice cream, alongside confectionery items such as chocolate, chewing gum and biscuits. The company has built a strong reputation for infant and medical nutrition, manufacturing specialty formulas designed to meet the needs of newborns and patients requiring tailored dietary support. Meiji’s product portfolio also features functional foods enriched with probiotics and other bioactive ingredients, reflecting its focus on combining taste with health benefits.
On the pharmaceutical side, Meiji develops and markets ethical drugs, over-the-counter preparations and veterinary products. Its research efforts encompass antibiotics, vaccines and treatments for lifestyle-related diseases, backed by in-house R&D facilities. Collaboration agreements with academic institutions and global partners bolster the company’s pipeline, aiming to address unmet medical needs both domestically and abroad.
Tracing its roots to early 20th-century dairy enterprises, Meiji consolidated its food and pharmaceutical operations under Meiji Holdings in 2009. Since then, it has pursued a strategy of steady international expansion, particularly throughout Asia, while maintaining strong market positions in Japan. Guided by a board of directors and senior management team, Meiji continues to balance innovation in health science with consumer-focused food products.
AI Generated. May Contain Errors.
Free MEJHY Stock Alerts